1. Research hotspots and emerging trends in mesenchymal stem/stromal cells in bronchopulmonary dysplasia.
- Author
-
Ao M, Ma H, Guo M, Dai X, and Zhang X
- Subjects
- Infant, Newborn, Humans, Bronchopulmonary Dysplasia therapy, Exosomes, Extracellular Vesicles, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation methods
- Abstract
Bronchopulmonary dysplasia (BPD) is a prevalent lung disease in neonates that is associated with numerous complications and high mortality. The promising approach to treat BPD is the use of mesenchymal stem cells (MSCs), However, the current treatment of MSCs presents safety concerns, including occlusion of blood vessels and tumorigenicity. In this study, relevant publications from the Web of Science Core Collection were downloaded in January 2023. The acquired data were analyzed and predicted for trends and hotspots in this field using CiteSpace software. Results revealed that in recent years, the focus of co-cited references has been primarily on the clinical studies of MSCs and the application of MSCs derivatives for treating BPD models. The keywords that have gained attention are extracellular vesicles and exosomes. The United States has emerged as the most influential co-authoring country in this field. Among the co-cited journals, the American Journal of Respiratory and Critical Care Medicine holds the highest influence. Thus, this study provides trends in publications, collaboration, research interests, and hotspots, and provides clues for novel ideas and strategies in to further MSCs treatments for BPD., (© 2023. The Author(s) under exclusive licence to Japan Human Cell Society.)
- Published
- 2024
- Full Text
- View/download PDF